Synthesis, structure and reactivity of phosphaferrocenes

by Wells, A. S.
Published 1987

The stratigraphy and structure of the Middleton Tyas-Sleightholme anticline and the development of chert between the underset and crow limestones in North Yorkshire

by Wells, A. J.
Published 1955

Regular generalized switching classes and related topics

by Wells, A. L.
Published 1982

An investigation of the project materials and project methods used by teachers to motivate the study of geography in the seventh and eighth grades

by Wells, A. Edwin
Published 2013

Middle Pennsylvanian fusulinids of the Naco Formation near Winkelman, Gila County, Arizona

by Wells, A. J., 1934-
Published 1965

Assessing Immune Response to SARS-CoV-2 Infection

by Shurin MR, Morris A, Wells A, Wheeler SE
Published 2020-06-01

DESIGN OPTIMIZATION OF THE HOLOS-QUAD MICRO-REACTOR CONCEPT

by Stauff N. E., Lee C. H., Wells A., Filippone C.
Published 2021-01-01

NEUTRONIC BENCHMARK ON HOLOS-QUAD MICRO-REACTOR CONCEPT

by Stauff N. E., Lee C. H., Shriwise P., Wells A., Filippone C.
Published 2021-01-01

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent

by Linfeng Li, Adedoyin D. Abraham, Qiong Zhou, Hadi Ali, Jeremy V. O'Brien, Brayden D. Hamill, John J. Arcaroli, Wells A. Messersmith, Daniel V. LaBarbera
Published 2014-09-01

Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer

by Colin D. Weekes, Dongweon Song, John Arcaroli, Lora A. Wilson, Belen Rubio-Viqueira, George Cusatis, Elizabeth Garrett-Mayer, Wells A. Messersmith, Robert A. Winn, Manuel Hidalgo
Published 2012-08-01

Measurement of the charged pion mass using a low-density target of light atoms

by Trassinelli M., Anagnostopoulos D.F., Borchert G., Dax A., Egger J.-P., Gotta D., Hennebach M., Indelicato P., Liu Y.-W., Manil B., Nelms N., Simons L.M., Wells A.
Published 2016-01-01

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

by Todd M. Pitts, Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman, John J. Tentler, Diana Cittelly, D. Ryan Ormond, Wells A. Messersmith, S. Gail Eckhardt, Jennifer R. Diamond
Published 2020-03-01

Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.

by Aaron J Scott, Eun-Kee Song, Stacey Bagby, Alicia Purkey, Martin McCarter, Csaba Gajdos, Kevin S Quackenbush, Benjamin Cross, Todd M Pitts, Aik Choon Tan, S Gail Eckhardt, Hubert Fenton, John Arcaroli, Wells A Messersmith
Published 2017-01-01

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models

by S. Lindsey eDavis, S. Lindsey eDavis, Kelli M. Robertson, Todd M. Pitts, Todd M. Pitts, John J. Tentler, John J. Tentler, Erica L. Bradshaw-Pierce, Erica L. Bradshaw-Pierce, Erica L. Bradshaw-Pierce, Peter J. Klauck, Stacey M. Bagby, Stephanie L. Hyatt, Heather M. Selby, Anna eSpreafico, Jeffrey A Ecsedy, John J. Arcaroli, John J. Arcaroli, Wells A. Messersmith, Wells A. Messersmith, Aik Choon eTan, Aik Choon eTan, S. Gail eEckhardt, S. Gail eEckhardt
Published 2015-06-01

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

by Sarah J. Hartman, Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu, S. Lindsey Davis, Alexis D. Leal, John J. Tentler, Jennifer R. Diamond, S. Gail Eckhardt, Wells A. Messersmith, Todd M. Pitts
Published 2021-03-01

Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer.

by Todd M Pitts, Timothy P Newton, Erica L Bradshaw-Pierce, Rebecca Addison, John J Arcaroli, Peter J Klauck, Stacey M Bagby, Stephanie L Hyatt, Alicia Purkey, John J Tentler, Aik Choon Tan, Wells A Messersmith, S Gail Eckhardt, Stephen Leong
Published 2014-01-01

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

by Peter J. Klauck, Stacey M. Bagby, Anna Capasso, Erica L. Bradshaw-Pierce, Heather M. Selby, Anna Spreafico, John J. Tentler, Aik Choon Tan, Jihye Kim, John J. Arcaroli, Alicia Purkey, Wells A. Messersmith, Keisuke Kuida, S. Gail Eckhardt, Todd M. Pitts
Published 2018-02-01